Abstract
Surveillance for antimicrobial resistance is important in terms of defining prevention and treatment strategies. While surveillance is routinely and efficiently carried out in developed countries, several major constraints often make it impossible for developing countries to carry out major surveillance programmes in this field. This chapter reviews the problems faced by the developing world in carrying out effective surveillance for antibiotic resistance and briefly describes the available data.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Adegbola, R.A., Hill, P.C., Secka, O., et al. 2006. Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996–2003. Trop Med Intl Health 11: 1128–1135.
Aires De Sousa, M., Santos Sanches, I., Ferro, M.L., De Lencastre, H. 2000. Epidemiological study of staphylococcal colonization and cross-infection in two West African Hospitals. Microb Drug Resist 6: 133–141.
Amir, M., Paul, J., Batchelor, B. et al. 1995. Nasopharyngeal carriage of Staphylococcus aureus and carriage of tetracycline-resistant strains associated with HIV-seropositivity. Eur J Clin Microbiol Infect Dis 14: 34–40.
Archibald, L.K., Reller, L.B. 2001. Clinical microbiology in developing countries. Emerg Infect Dis 7: 302–305.
Bell, J.M., Turnidge, J.D., Jones, R.N. et al. 2002a. Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998–1999) including an in vitro evaluation of BMS284756. Int J Antimicrob Agents 19: 125–132.
Bell, J.M., Turnidge, J.D., Gales, A.C. et al. 2002b. Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998–99). Diagn Microbiol Infect Dis 42: 193–198.
Bell, J.M., Turnidge, J.D., Jones, R.N. et al. 2003. Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998–2001. javascript:AL_get(this, ‘jour’, ‘Antimicrob Agents Chemother.’); Antimicrob Agents Chemother 47: 3989–3993.
Blomberg, B., Mwakagile, D.S., Urassa, W.K., et al. 2004. Surveillance of antimicrobial resistance at a tertiary hospital in Tanzania. BMC Public Health 4: 45.
Blomberg, B., Olsen, B.E., Hinderaker, S.G. et al. 2005. Antimicrobial resistance in urinary bacterial isolates from pregnant women in rural Tanzania: implications for public health. Scand J Infect Dis 37: 262–268.
Borg, M.A., Scicluna, E., de Kraker, M., et al. 2006. Antibiotic resistance in the southeastern Mediterranean – preliminary results from the ARMed project. Euro Surveill 11: 164–167.
Bouchillon, S.K., Johnson, B.M., Hoban, D.J. et al. 2004. Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001–2002. Int J Antimicrob Agents 24: 119–124.
Brink, A., Moolman, J., da Silva, M.C., et al. 2007. Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa. S Afr Med J 97: 273–279.
Denno, D.M., Frimpong, E., Gregory, M., Steele, R.W. 2002. Nasopharyngeal carriage and susceptibility patterns of Streptococcus pneumoniae in Kumasi, Ghana. West Afr J Med 21: 233–236.
Feikin, D.R., Davis, M., Nwanyanwu, O.C. et al. 2003. Antibiotic resistance and serotype distribution of Streptococcus pneumoniae colonizing rural Malawian children. Pediatr Infect Dis J 22: 564–567.
Felmingham, D., White, A.R., Jacobs, M.R. et al. 2005. The Alexander Project: the benefits from a decade of surveillance. J Antimicrob Chemother 56 Suppl 2: ii3–ii21.
Frost, J.A., Rowe, B., Vandepitte, J. 1982. Acquisition of trimethoprim resistance in epidemic strains of Shigella dysenteriae type 1 from Zaire. Lancet 8278: 963.
Guévart, E., Solle, J., Mouangue, A. et al. 2006. Antibiotic susceptibility of Vibrio cholerae 01: evolution after prolonged curative and preventive use during the 2004 cholera epidemics in Douala (Cameroon). Med Mal Infect 36: 329–334.
Hill, P.C., Akisanya, A., Sankareh, K. et al. 2006. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers. Clin Infect Dis 43: 673–769.
Hirakata, Y., Matsuda, J., Miyazaki, Y. et al. 2005. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998–2002). Diagn Microbiol Infect Dis 52: 323–329.
Hsu, L.Y., Tan, T.Y., Jureen, R. et al. 2007. Antimicrobial drug resistance in Singapore hospitals. Emerg Infect Dis 13: 1944–1947.
Huebner, R.E., Wasas, A.D., Klugman, K.P. 2000. Trends in antimicrobial resistance and serotype distribution of blood and cerebrospinal fluid isolates of Streptococcus pneumoniae in South Africa, 1991–1998. Int J Infect Dis 4: 214–218.
Kacou-N’douba, A., Guessennd-Kouadio, N., Kouassi-M'bengue, A., Dosso, M. 2004. Evolution of Streptococcus pneumoniae antibiotic resistance in Abidjan: update on nasopharyngeal carriage, from 1997 to 2001 Med Mal Infect 34: 83–85.
Kariuki, S., Cheesbrough, J., Mavridis, A.K., Hart, C.A. 1999. Typing of salmonella enterica serotype paratyphi C isolates from various countries by plasmid profiles and pulsed-field gel electrophoresis. J Clin Microbiol 37: 2058–2060.
Kariuki, S., Revathi, G., Kariuki, N. et al. 2005. Increasing prevalence of multidrug-resistant non-typhoidal salmonellae, Kenya, 1994–2003. Int J Antimicrob Agents 25: 38–43.
Kariuki, S., Revathi, G., Kiiru, J., Lowe, B., Berkley, J.A., Hart, C.A. 2006. Decreasing prevalence of antimicrobial resistance in non-typhoidal Salmonella isolated from children with bacteraemia in a rural district hospital, Kenya. Int J Antimicrob Agents 28:166–171.
Kesah, C., Ben Redjeb, S., Odugbemi, T.O. et al. 2003. Prevalence of methicillin-resistant Staphylococcus aureus in eight African hospitals and Malta. Clin Microbiol Infect 9: 153–156.
Lamikanra, A., Paul, B.D., Akinwole, O.B., Paul, M.O. 1985. Nasal carriage of Staphylococcus aureus in a population of healthy Nigerian students. J Med Microbiol 19: 211–216.
Lee, K., Lim, C.H., Cho, J.H. et al. 2006. High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004. Yonsei Med J 47: 634–645.
Liebowitz, L.D., Slabbert, M., Huisamen, A. 2003. National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents. J Clin Pathol 56: 344–347.
Malengreau, M., Molima-Kaba, Gillieaux, M., de Feyter, M., Kyele-Duibone, Mukolo-Ndjolo. 1983. Outbreak of Shigella dysentery in eastern Zaire, 1980–1982. Ann Soc Belge Med Trop 63: 59–67.
Mathai, E., Chandy, S., Thomas, K., et al. 2008. Antimicrobial resistance surveillance among commensal Escherichia coli in rural and urban areas in Southern India. Trop Med Int Health13: 41–45.
Mehta, A., Rosenthal, V.D., Mehta, Y., et al. 2007. Device-associated nosocomial infection rates in intensive care units of seven Indian cities. Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect 67: 168–174.
Mukonyora, M., Mabiza, E., Gould, I.M. 1985. Staphylococcal bacteraemia in Zimbabwe 1983. J Infect 10: 233–239.
Nkuo-Akenji, T.K., Ntemgwa, M.L., Ndip, R.N. 2001. Asymptomatic salmonellosis and drug susceptibility in the Buea District, Cameroon. Cent Afr J Med 47: 254–257.
Obi, C.L., Makandiramba, B., Robertson, V., Tswana, S.A., Moyo, S.R., Nziramasanga, P. 1998. In-vitro activity of piperacillin and tazobactam combination against clinically significant bacteria. East Afr Med J 75: 162–165.
Ochiai, R.L., Acosta, C.J., Agtini, M. et al. 2007. The use of typhoid vaccines in Asia: the DOMI experience. Clin Infect Dis 45 Suppl 1: S34–S38.
Ochiai, R.L., Acosta, C.J., Danovaro-Holliday, M.C., et al. 2008. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ 86: 260–268.
Okeke, I.N., Fayinka, S.T., Lamikanra, A. 2000. Antibiotic resistance in Escherichia coli from Nigerian students, 1986–1998. Emerg Infect Dis. 6: 393–396.
Okeke, I.N., Aboderin, O.A., Byarugaba, D.K., Ojo, K.K., Opintan, J.A. 2007. Growing problem of multidrug-resistant enteric pathogens in Africa. Emerg Infect Dis 13: 1640–1646.
Petti, C.A., Polage, C.R., Quinn, T.C., Ronald, A.R., Sande, M.A. 2006. Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis 42: 377–382.
Seydi, M., Sow, A.I., Soumare, M. et al. 2004. Staphylococcus aureus bacteremia in the Dakar Fann University Hospital. Med Mal Infect 34: 210–215.
Shittu, A.O., Lin, J. 2006. Antimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province, South Africa. BMC Infect Dis 6: 125.
Song, J.H., Sung, S.I., Ko, K.S. et al. 2004. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 48: 2101–2107.
Srikantiah, P., Girgis, F.Y., Luby, S.P., et al. 2006. Population-based surveillance of typhoid fever in Egypt. Am J Trop Med Hyg 74: 114–119.
Stelling, J.M., O’Brien, T.F. 1997. Surveillance of antimicrobial resistance: the WHONET program. Clin Infect Dis 24 Suppl 1: S157–S168.
Urassa, W.K., Mhando, Y.B., Mhalu, F.S., Mjaonga, S.J. 2000. Antimicrobial susceptibility pattern of Vibrio cholerae O1 strains during two cholera outbreaks in Dar es Salaam, Tanzania. East Afr Med J 77: 350–353.
Van den Ende, J. 2007. Antibiotic resistance in hospitals – are surveillance data of any value? S Afr Med J 2007 97: 264–266.
Vaughan, J.P., Walt, G. 1984. Implementing primary health care: some problems of creating national programmes. Trop Doct 14: 108–113.
Von Seidlein, L., Kim, D.R., Ali, M. et al. 2006. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med 3: e353.
WHO Global Strategy for Containment of Antimicrobial Resistance. WHO/CDS/CSR/DRS/2001.2.
Zinn, C.S., Westh, H., Rosdahl, V.T. et al. 2004. An international multicenter study of antimicrobial resistance and typing of hospital Staphylococcus aureus isolates from 21 laboratories in 19 countries or states. Microb Drug Resist 10: 160–168.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Vlieghe, E., Bal, A., Gould, I.M. (2010). Surveillance of Antibiotic Resistance in Developing Countries: Needs, Constraints and Realities. In: Sosa, A., Byarugaba, D., Amábile-Cuevas, C., Hsueh, PR., Kariuki, S., Okeke, I. (eds) Antimicrobial Resistance in Developing Countries. Springer, New York, NY. https://doi.org/10.1007/978-0-387-89370-9_26
Download citation
DOI: https://doi.org/10.1007/978-0-387-89370-9_26
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-89369-3
Online ISBN: 978-0-387-89370-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)